Trials tagged with: "acute myelogenous leukemia (aml)"
A phase 2 open label, AC220 monotherapy efficacy study in patients with acute myeloid leukaemia (AML) with FLT3-ITD activating mutations.
Browse by popular tags
ac220 acute myelogenous leukemia (aml) acute myeloid leukaemia aml b-cell chronic lymphocytic leukaemia blood cancers bone marrow cll cll210 clonal blood cell disorders continuum trial flt3-itd follicular genetic factors mud haematopoiesis high risk mds itp lenalidomide lenaric leukaemia leukaemic stem cell biology mds multicenter myeloma myeloproliferative disorders non apl parallel group phase 3 placebo controlled
The Clinical research facility is part of the NIHR and is funded by the Department of Health